RHEACELL

Serial Number 79229551
Registration 5694020
739

Registration Progress

Application Filed
Feb 5, 2018
Under Examination
Approved for Publication
Dec 25, 2018
Published for Opposition
Dec 25, 2018
Registered
Mar 12, 2019

Trademark Image

RHEACELL

Basic Information

Serial Number
79229551
Registration Number
5694020
Filing Date
February 5, 2018
Registration Date
March 12, 2019
Published for Opposition
December 25, 2018
Drawing Code
3

Status Summary

Current Status
Active
Status Code
739
Status Date
Jul 7, 2025
Registration
Registered
Classes
005 042 044

Rights Holder

RHEACELL GmbH & Co. KG

28
Address
Im Neuenheimerfeld 517
Heidelberg 69120
DE

Ownership History

RHEACELL GmbH & Co. KG

Original Applicant
28
69120 Heidelberg DE

RHEACELL GmbH & Co. KG

Owner at Publication
28
69120 Heidelberg DE

RHEACELL GmbH & Co. KG

Original Registrant
28
Heidelberg DE

Legal Representation

Attorney
Claudia W. Stangle

USPTO Deadlines

Next Deadline
1276 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-03-12)
Due Date
March 12, 2029
Grace Period Ends
September 12, 2029

Application History

35 events
Date Code Type Description Documents
Jul 7, 2025 NA75 E NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Loading...
Jul 7, 2025 C75A O REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Loading...
Jun 30, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 27, 2025 ES75 I TEAS SECTION 71 & 15 RECEIVED Loading...
Mar 12, 2024 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Jan 4, 2024 RNWL P INTERNATIONAL REGISTRATION RENEWED Loading...
Jul 19, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jul 1, 2019 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jul 1, 2019 FIMP P FINAL DISPOSITION PROCESSED Loading...
Jun 12, 2019 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Mar 12, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 25, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 25, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 5, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 13, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 23, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 23, 2018 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Oct 19, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 19, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 10, 2018 CNFR O FINAL REFUSAL MAILED Loading...
Sep 10, 2018 CNFR R FINAL REFUSAL WRITTEN Loading...
Aug 21, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 21, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 21, 2018 ALIE A ASSIGNED TO LIE Loading...
Aug 1, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 8, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
May 23, 2018 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 23, 2018 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 19, 2018 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 18, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 17, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2018 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Mar 31, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 29, 2018 SDRC M SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical [ and veterinary ] preparations for treatment of skin diseases; pharmaceutical [ and veterinary ] preparations for the treatment of vertigo; pharmaceutical [ and veterinary ] preparations for treatment of nausea; [ pharmaceutical and veterinary preparations for treatment of vomiting; pharmaceutical and veterinary preparations for treatment of migraine; ] pharmaceutical [ and veterinary ] preparations for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, [ the urinary system, ] the integumentary system [, and the reproductive system ]; pharmaceutical [ and veterinary ] preparations for treatment of blood diseases and disorders; pharmaceutical [ and veterinary ] preparations, namely, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical [ and veterinary ] preparations for wound healing; pharmaceutical [and veterinary preparations for anti-aging, namely, stem cells for medical and aesthetic purposes, [ fibroblasts for medical and aesthetic purposes, ] surgical tissue implants obtained from stem cells [ , surgical tissue implants obtained from fibroblasts ]
Class 042
Scientific and technological services, namely medical and scientific research services in the fields of regenerative medicine and tissue engineering, scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, consulting services relating to scientific research in the fields of regenerative medicine and tissue engineering, providing information on medical and scientific research on pharmaceutical products, providing information in the form of expert reports relating to scientific research in the fields of regenerative medicine and tissue engineering; Industrial analysis, namely chemical analysis; research services, namely laboratory research services relating to pharmaceuticals, medical, biomedical and stem cell research in the field of regenerative medicine and tissue engineering, scientific and medical research and development for medical purposes in the field of regenerative medicine and tissue engineering, research and development services relating to new products for others, research in the field of biotechnology, research in the field of gene therapy, research and development in the field of immunology, research and development in the field of antibodies, research and development in the field of antibody technology, research and development in the field of bacteriology, research and development in the field of gene expression systems, research and development in the field of vaccines, pharmaceutical research and development services, research and development services in the field of biotechnology
Class 044
Medical services

Additional Information

Design Mark
The mark consists of the stylized word "RHEACELL" above a design consisting of two arrowheads making an "X" design.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "RHEACELL" has no meaning in a foreign language.

Classification

International Classes
005 042 044